Publisher Responsibility: The publisher made every effort to ensure accuracy based on publicly available information
However, some individuals whove been trying to lose weight for a very long time, jumping from one diet or programme to another, may need extra support to keep weight off in the long term
Eligibility and dosing The tablet is licensed for adults with obesity, with a body mass index (BMI) of 30 or above, or those who are overweight with a BMI between 27 and 30 with at least one weight-related comorbidity, alongside a reduced-calorie diet and increased physical activity
However, it should be up to a knowledgeable healthcare professional to decide when and if to use these drugs for off-label use. Wegovy vs
For multi-dose pens such as Ozempic (semaglutide) and Saxenda (liraglutide), different in-use storage periods apply